» Articles » PMID: 26449725

Cord Blood Banking - Bio-objects on the Borderlands Between Community and Immunity

Overview
Publisher Biomed Central
Specialty Medical Ethics
Date 2015 Oct 10
PMID 26449725
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Umbilical cord blood (UCB) has become the focus of intense efforts to collect, screen and bank haematopoietic stem cells (HSCs) in hundreds of repositories around the world. UCB banking has developed through a broad spectrum of overlapping banking practices, sectors and institutional forms. Superficially at least, these sectors have been widely distinguished in bioethical and policy literature between notions of the 'public' and the 'private', the commons and the market respectively. Our purpose in this paper is to reflect more critically on these distinctions and to articulate the complex practical and hybrid nature of cord blood as a 'bio-object' that straddles binary conceptions of the blood economies. The paper draws upon Roberto Esposito's reflections on biopolitics and his attempt to transcend the dualistic polarisations of immunity and community, or the private and the public. We suggest that his thoughts on immunitary hospitality resonate with many of the actual features and realpolitik of a necessarily internationalised and globally distributed UCB 'immunitary regime'.

Citing Articles

The politics of suspension suspended: the curious case of a cryopreserved cell product.

Liburkina R Biosocieties. 2024; 19(4):595-612.

PMID: 39552729 PMC: 11564079. DOI: 10.1057/s41292-024-00328-z.


Editors introduction: biobanks as sites of bio-objectification.

Stephens N, Brown N, Douglas C Life Sci Soc Policy. 2018; 14(1):6.

PMID: 29468472 PMC: 5821615. DOI: 10.1186/s40504-018-0070-5.

References
1.
Samuel G, Kerridge I, Vowels M, Trickett A, Chapman J, Dobbins T . Ethnicity, equity and public benefit: a critical evaluation of public umbilical cord blood banking in Australia. Bone Marrow Transplant. 2007; 40(8):729-34. DOI: 10.1038/sj.bmt.1705812. View

2.
Brown N, Machin L, McLeod D . Immunitary bioeconomy: the economisation of life in the international cord blood market. Soc Sci Med. 2011; 72(7):1115-22. DOI: 10.1016/j.socscimed.2011.01.024. View

3.
Cutler C, Ballen K . Improving outcomes in umbilical cord blood transplantation: state of the art. Blood Rev. 2012; 26(6):241-6. DOI: 10.1016/j.blre.2012.08.001. View

4.
Brown N . Contradictions of value: between use and exchange in cord blood bioeconomy. Sociol Health Illn. 2012; 35(1):97-112. DOI: 10.1111/j.1467-9566.2012.01474.x. View

5.
Busby H, Kent J, Farrell A . Revaluing donor and recipient bodies in the globalised blood economy: transitions in public policy on blood safety in the United Kingdom. Health (London). 2013; 18(1):79-94. PMC: 3930469. DOI: 10.1177/1363459313476966. View